| BXRX Market Cap History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the BXRX market cap history going back to 11/14/2019:
Also see: BXRX Shares Outstanding History and BXRX YTD Return |
As of 8/8/2023 Baudax Bio has a market cap of 4.20 million. Investors often follow the BXRX market cap history to compare the size of the company over time.
This page shows BXRX market capitalization trends over time, with 16 market cap datapoints presented, dating back to 11/14/2019.

| BXRX Market Cap History Table | ||||||||||||||||||||||||||||||||||
Below is a table of the BXRX market cap history going back to 11/14/2019:
Also see: BXRX Shares Outstanding History and BXRX YTD Return |
| BXRX Market Cap History Chart | |||||||||||||||||||||||||||||||||||
BXRX Historical Market Cap: -51.75% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||
| BXRX Stock Price Chart |
| About Baudax Bio Inc |
| Baudax Bio is a pharmaceutical company primarily focused on commercializing and developing products for hospital and related acute care settings. Co. has launched its commercial product, ANJESO in the U.S. ANJESO is an intravenous analgesic agent. ANJESO is a cyclooxygenase-2 preferential, non-steroidal anti-inflammatory, or NSAID for the management of moderate to severe pain, which can be administered alone or in combination with other non-NSAID analgesics. Co.'s pipeline also includes other earlier stage product candidates including intermediate and short-acting neuromuscular blocking agents, and accompanying reversal agents that Co. is developing for use in hospital or related settings. We show 16 historical shares outstanding datapoints in our BXRX shares outstanding history coverage, used to compute BXRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing BXRX market cap history over the course of time is important for investors interested in comparing BXRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of BXRX versus a peer is one thing; comparing BXRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like BXRX can fluctuate over the course of history. With this page we aim to empower investors researching BXRX by allowing them to research the BXRX market cap history. |
| BXRX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| BXRX Share Performance |
| Market Cap Peers |
| Baudax Bio (BXRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CABA Market Cap History CADL Market Cap History CAH Market Cap History CALA Market Cap History CALC Market Cap History CANO Market Cap History CAPN Market Cap History CAPR Market Cap History CARA Market Cap History CARM Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.